Categories
Rossari Biotech Limited — Updates, 28-04-2026: Press Release
28-04-2026 · 01:58 pm
Rossari Biotech reports record Q4: Revenue up 18% to ₹684.9 Cr, PAT up 34% to ₹46.0 Cr. FY26 revenue at ₹2,396.4 Cr, PAT at ₹149.2 Cr. Company commissioned 15,000 MTPA ethoxylation capacity and a new R&D facility. Declared ₹0.50/share dividend.
No comments yet. Be the first to comment!